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ABSTRACT:  A new receipe consisting of Phyllanthus fraternus Webster, Eclipta alba and 
curcumin was prepared.  The efficacy of this preparation was tested in carbontetrachloride 
(CCl4) induced fatty liver model in rats.  This preparation was able to normalize the level of 
lipids accumulating in liver due to CCl4 injury and it was also able to bring down elevated levels 
of serum bilirubin.  Further, the decreased levels of serum triglycerides, pre B-lipoproteins and 
cholesterol in CCl4 liver injured rats was raised after treatment with new preparation.  Further, 
the decreased level of liver glycogen was also normalized.  From these results, it can be inferred 
that the new receipe is able to offer protection against the liver injury caused by CCl4 injection. 
 
INTRODUCTION 
 
It is well known that in hepatic jaundice, the 
liver is affected.  Similarly when rats are 
injected with CCl4 the liver gets damaged.  
The herbal drugs which are mentioned to be 
beneficial in the treatment of viral hepatitis 
and toxic jaundice have been tested in CCl4 
liver injury rate model (Nazimuddin et al, 
1981 and Khin MaMa, 1978).  As a result of 
CCl4  introxication, accumulation of fat in 
the liver and necrosis in the centribular 
region of the liver occur.  Recknagel et al, 
1960 have suggested that the accumulation 
of fat in the liver due to CCl4 administration 
is due to the failure of the liver in 
incorporating triglycerides into lipoproteins 
and its transport.  This defect might arise 
from the disorganization of endoplasmic-
reticulum early after CCl4  administration.  
As a consequences, the microsomal enzyme 
activities are found to decrease.  Further, the 
lipid peroxidation caused by CCl4 affects the 
microsonal membrane system rich in 
lipoproteins (Recknagel et al 1977).  Since 
lipid peroxidation damages membrane 
lipids, the water soluble enzymes leak into 
plasma from the liver (Recknagel and 
Glende, 1973).  Rao et al  (1970) have 
suggested that vitamin-E, inhibitors of lipid 
peroxidation, free radicals scavengers and 
radio-protective drugs are able to protect the 
animals from CCl4  induced  hepatotoxicity.  
Our previous results (Chandra et al, 1985, 
Chandra and Sadique 1986a, Chandra and 
Sadique 1986b) have indicated that P. niruri, 
E. alba and curcumin were able to prevent 
the liver injury in rats subjected to CCl4 
intoxication.  Therefore a recipe containing 
these drugs was prepared and its effect on 
CCl4  induced liver injury in rats was 
investigated. 
 
MATERIALS AND METHODS 
Induction of fatty liver: 
 
Male albino wistar rats weighing 150 – 200 
grams purchased from private animal farm, Pages  99 - 103 
Bangalore were fed with rat Pellet food 
(Hindustan Liver Limited, Bangalore) and 
water  ad libitum:  The rats were injected 
with CCl4  (0.5 ml / Kg.b.w.) by I.P. 
everyday for five days, so as to induce the 
liver injury (Cameron and Karunaratne, 
1936). 
 
TABLE – I 
 
The effect of new recipe on lipid content of the liver in rats during CCl4 induced liver 
injury. 
 
No.  Group  Total lipids in mg/Kg liver tissue 
1 
 
2 
 
3 
Normal 
 
CCl4 administered 
 
CCl4  and new recipe 
administered  
65.4 ± 2.5
a 
 
170.5 ± 6.1 
 
76.0 ± 2.9
a 
 
 
 
Each value is the mean of 6 rats ± s.e.m 
A= ‘p’ value < 0.001 
 
Medication 
 
Drug combination (new recipe) was 
prepared using shade dried leaves of E.alba, 
P. niruri  and Curcumin (25:15:10).  This 
drug suspended in 2% gum acacia was 
orally administered to a group consisting of 
6 rats which were injected with CCl4.  
Similarly, the control group received 2% 
gum acacia alone.  The drug administration 
was initiated on the day of injection of CCl4 
and it was continued up to 9
th day.  On the 
10
th  day, the animals were sacrified by 
decapitation, the blood was collected in test 
tubes and they were kept in room 
temperature for 30 minutes, then they were 
kept in refrigerator overnight, and the clear 
serum was prepared after centrifugation.   
The liver was perfused with 0.9% saline, 
they glycogen was separated and assayed 
using anthrone method (Hassid and 
Abraham 1957).  Further, they liver lipids 
were extracted with a mixture of chloroform 
and methanol, and the chloroform fraction 
having lipids was evaporated to dryness.  
After aeration the weight was determined for 
total lipids (King and Wooten, 1959). 
 
Serum analysis 
 
Serum cholesterol (Skalar auto-analyser 
method), bilirubin (Wooten, 1974) and 
triglyceride (Soloni, 1971) were analysed.   
Serum was subjected to electrophoresis in 
cellulose acetate membranes and the 
percentage distribution of various 
lipoproteins were determined (Debalts & 
Lezy 1971). 
 
RESULTS AND DISCUSSION 
 
A drug combination containing E. alba, P. 
niruri and curcumin (25:15:10) was tested in 
CCl4  induced liver injury in rats.  It was 
found that a dose of 50mg/ 100 g.b.w was 
found to be effective and so this dose was Pages  99 - 103 
used throughout the experiment.  The liver 
injury caused by CCl4  is due to the 
accumulation of lipid in the liver (Recknagel 
et al  1960).  From Table I, it can be 
understood that the lipid level which is 
elevated after CCl4  treatment has been 
normalized after treatment with new recipe. 
 
It is well known that the serum billirubin 
level is elevated in hepatic jaundice (varley, 
1980).  Similarly, there are reports to 
indicate that serum bilirubin level is elevated 
in CCl4  poisoning (Dahiya et al,  1980).  
From Table-II, it can be noted that the 
elevated serum bilirubin level in CCl4 
intoxication has been reduced after 
treatment with new recipe, indicating the 
beneficial effect of the drug. 
 
TABLE – II 
 
The effect of new recipe on serum billirubin level during CCl4 induced liver injury in rats. 
 
No.  Group  Dose (mg / 
100 g.b.w.) 
Serum Bilirubin level mg/100 ml 
Total  Conjugated  Un 
conjugated 
1 
 
2 
 
3 
Normal 
 
CCl4 administered 
 
CCl4 and new recipe administered 
 
- 
 
Vehicle 
 
50 
0.28 
 
0.57 
 
0.28 
0.28 
 
0.28 
 
0.28 
- 
 
0.28 
 
- 
 
The values represent the average of three experiments. 
 
TABLE – III 
 
The effect of new recipe on serum triglyceride level during CCl4 induced liver injury in 
rats. 
 
No.  Group  Dose (mg/100 g.b.w.)  Triglyceride level 
(mg/100ml) 
1 
 
2 
 
3 
Normal 
 
CCl4 administered 
 
CCl4 and new recipe administered 
- 
 
Vehicle 
 
50 
186 ± 15.2
a 
 
120 ± 10.5 
 
160 ± 8.5
a 
 
 
Each value is the mean of 6 rats ± s.e.m 
a = ‘p’ value < 0.001 Pages  99 - 103 
 
 
TABLE – IV 
 
The effect of new recipe on serum cholesterol in CCl4 induced liver injury in rats. 
 
No.  Group  Dose (mg/100 g.b.w.)  Triglyceride level 
(mg/100ml) 
1 
 
2 
 
3 
Normal 
 
CCl4 administered 
 
CCl4 and new recipe administered 
- 
 
Vehicle 
 
50 
44.52 ± 3.9
b 
 
42.2 ± 3.5 
 
48.76 ± 4.6
a 
 
 
Each value represents the mean of 6 rats ± s.e.m. 
a = ‘p’ value < 0.005 
b = ‘p’ value < 0.05 
 
It is well known the immediately after CCl4 
administration, the triglyceride level in the 
liver is elevated (Schotz & Recknagel 1960).  
Further, the defect in the transport of 
triglycerides into plasma is the cause for 
accumulation of lipids in the liver during 
CCl4 intoxication (Stetten & Salcedo, 1944).  
It has been reported that the transport of 
plasma fatty acids into the liver and their 
conversion into triglycerides occur normally 
even during CCl4 intoxication.  But there is 
an inhibition in the transport of triglyceride 
into plasma (Steinberg, 1963).   
Maximchunck and Rubinstein, (1963), have 
reported that within 3.5 hours after 
administration of CCl4 a decrease in serum 
triglyceride level occurred in rats.  So, these 
evidences are in support of the view that 
CCl4  intoxication evokes a defect in the 
secretory mechanism of triglyceride in the 
liver resulting in accumulation of lipid in the 
liver.  From Table III, it can be noted that 
when compared with the normal levels the 
serum  triglycerides  and cholesterol were 
showing lesser values in CCl4 treated rats.  
However, the administration of new receipt 
to CCl4  intoxicated rats has raised  these 
values.  So, it is likely that the elevations in 
these levels after drug administration may be 
due to rectification of the defective secretory 
mechanism of lipids associated with the 
CCl4  injury.  Normally triglycerides are 
transported into the plasma from the liver as 
lipoproteins.  Seakins & Robinson, (1963) 
have reported the inhibition in the synthesis 
of the protein  components (apoprotein) of 
the lipoproteins during CCl4  intoxication.  
So, a reduction in the synthesis of 
lipoproteins will result in the lowered 
transport of triglycerides which will be 
associated with the lipoproteins.  As a 
consequence, the plasma neutral lipids get 
decreased whereas liver lipid levels get 
increased (Seakins & Robinson, 1963).  So, 
it is apparent that the defective secretory 
mechanism of triglycerides in liver 
poisoning is due to the inhibition in the 
synthesis of apoprotein of the lipoproteins.  
Further, it has been reported by the same 
workers that liver slices incubated with CCl4 
were able to incorporate C
14-leucine at 
reduced rate into plasma lipoproteins and 
liver proteins. 
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 In plasma, triglycerides exist almost as 
lipoproteins.  In the fasting rats, 65% of the 
total triglyceride is found associated with the 
very low density lipoproteins (pre β-
lipoproteins) (Lombardi & Ugarize, 1965).   
This lipoprotein serves as the vehicle for the 
transport of liver-triglyceride into plasma.   
From Table V, it can be noticed that serum 
pre  β-lipoprotein was only 17.2% during 
CCl4 injury, whereas it showed a value of 
31.4% after treatment which new drug 
combinations.  From this result, it can be 
inferred that the new receipt is able to 
relieve the inhibition in the synthesis of 
apoprotein lipoprotein leading to 
normalization of  defective triglyceride 
secretory mechanism. 
 
It is well known that the administration of 
CCl4  to rats leads to a decrease glycogen 
content of the liver (Dolak, et al. 1985), 
during the liver injury.  The enzyme 
phosphorylase-A, which is involved in the 
degradation of glycogen is stimulated.  But 
there are reports to indicate that the loss of 
liver glycogen is not due to stress induced 
catecholamine secretion (Recknagel, et al, 
1986).  Further, the activity of glycogen 
synthesis which is involved in the synthetase 
of glycogen has been reported to decrease 
during CCl4 injury.  So, its likely that loss of 
liver glycogen during CCl4  injury may be 
due to either stimulation of phosphorylase-A 
or by stimulating glycogen synthetase, or by 
both the mechanisms. 
 
From all these observations, it may be 
concluded that the new recipe is able to 
afford protection against CCl4 induced liver 
INJURY.  It is already established by our 
earlier experiments that E.alba, P. fratuerus 
hrbster and curcumin of Curcuma longa are 
endowed with the property of preventing 
liver damage caused by CCl4.  In addition, it 
has been reported that curcumin isable to 
prevent the lipid peroxidation (Sharma, 
1976) and it also possesses anti-
inflammatory frogerty (Srimal, et al, 1971).  
So it is likely that the new recipe will exert 
beneficial effects in human jaundice (due to 
viral infection or liver damage). 
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